| Q37070395 | A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease |
| Q29416986 | APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study |
| Q35600979 | Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia |
| Q37104891 | Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs. |
| Q35648122 | Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysis |
| Q38372480 | Cholinergic modulation of the hippocampal region and memory function |
| Q92199453 | Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening |
| Q36014695 | Executive Dysfunction in MCI: Subtype or Early Symptom |
| Q38967438 | Fibrillar β-amyloid 1-42 alters cytokine secretion, cholinergic signalling and neuronal differentiation |
| Q40374258 | Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-β amyloidosis |
| Q92649227 | Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer's Disease Status and Risk Genotype |
| Q36769219 | PET radiopharmaceuticals for probing enzymes in the brain |
| Q37199221 | Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders |
| Q37158584 | Plasma acetylcholinesterase activity correlates with intracerebral β-amyloid load |
| Q34305083 | Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals |
| Q34556953 | Plasma proteins predict conversion to dementia from prodromal disease |
| Q30497749 | Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease |
| Q34804797 | Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway |
| Q36349870 | Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men. |
| Q57110843 | Soluble Aβ42 Acts as Allosteric Activator of the Core Cholinergic Enzyme Choline Acetyltransferase |
| Q40098573 | The diabetic brain and cognition |
| Q53091166 | The synergistic risk effect of apolipoprotein ε4 and DNA (cytosine-5-)-methyltransferase 3 beta (DNMT3B) haplotype for Alzheimer's disease. |
| Q30845482 | Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease |